Roderick MacKinnon is Director at Flex Pharma, Inc. (FLKS). They have made 1 open-market trade across 1 company since 2016, most recently 2016-03-11.
CIK 0001634768
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $70K since 2016, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FLKS | 431,277 | $262K |
Shares reported on the most recent Form 4, priced at the 2016-03-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FLKS | BUY | 2016-03-11 | 2016-03-15 | $7.03 | $70K | +3.4% | +27.0% | +19.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.